Hairy Cell Leukemia

Hairy cell leukemia is a type of blood cancer involving the excess production of lymphocytes. Here is the latest research on hairy cell leukemia.

May 1, 2020

Biology and Treatment of Hairy Cell Leukemia

Current Treatment Options in Oncology
Jerome Paillassa, Xavier Troussard
June 23, 2020
Case Report
Open Access

Rare Causes of Isolated and Progressive Splenic Lesions: Challenges in Differential Diagnosis, Evaluation, and Treatment of Primary Splenic Lymphomas

Clinical Medicine Insights. Blood Disorders
Ryan B SinitDavid M Aboulafia
April 28, 2020

Evaluation of CD160 and CD200 Expression as Differentiating Markers between Chronic Lymphocytic Leukemia and Other Mature B-Cell Neoplasms

International Journal of Hematology-oncology and Stem Cell Research
Wafaa Ahmed El-NeanaeySara Mohamed Abu-Shelou
August 7, 2020

Concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and hairy cell leukemia: clinical, pathologic and molecular features

Leukemia & Lymphoma
Ifeyinwa Emmanuela ObiorahKatherine R Calvo
May 16, 2020
Open Access

Atypical presentation of hairy cell leukemia: a report and comprehensive review

Blood Research
Sandeep Abhijit PattnaikShruti Mishra
August 29, 2020

The impact of hybrid contact lenses on keratoconus progression after accelerated transepithelial corneal cross-linking

International Ophthalmology
Mehmet Gökhan AslanFeyzahan Uzun
May 6, 2020

Superconductivity in the Electron-Doped Chevrel Phase Compound Mo6 S6.8 Te1.2

Inorganic Chemistry
Feng LinFuqiang Huang
May 8, 2020

The pharmacological management of hairy cell leukemia

Expert Opinion on Pharmacotherapy
Jorge Ramos Perez, Farhad Ravandi-Kashani
May 18, 2020
Case Report

Remission of early persistent cladribine-induced neutropenia after filgrastim therapy in a patient with Relapsing - Remitting Multiple Sclerosis

Multiple Sclerosis and Related Disorders
Giorgia T ManiscalcoCiro Florio
May 5, 2020
Open Access

Clinicopathological spectrum of hairy-cell leukemia: A single-center study with brief review of Indian literature

Journal of Cancer Research and Therapeutics
Ruchi GuptaSoniya Nityan
May 19, 2020

Prognostic Value of Baseline Serum Lactate Dehydrogenase Level in Patients With Hairy Cell Leukemia

Clinical Lymphoma, Myeloma & Leukemia
Senem MaralImdat Dilek
June 25, 2020
Open Access

Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update

Bryan D Fleming, Mitchell Ho
September 8, 2020

Treatment of hairy cell leukemia

Expert Review of Hematology
Dai Chihara, Robert J Kreitman
August 24, 2020

Ophthalmological findings in patients with leukaemia in a Colombian population

Archivos de la Sociedad Española de Oftalmología
C M RangelH Rodriguez
June 20, 2020

Atypical features of cutaneous adverse drug reactions during therapy for hairy cell leukemia

The Journal of Allergy and Clinical Immunology. in Practice
Julie CastagnaAngèle Soria
June 17, 2020
Open Access

A BRAF Negative Classic Hairy Cell Leukemia Patient in Long Lasting Complete Remission after Rituximab and Pentostatin

Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology
Alessandro GozzettiMonica Bocchia
May 29, 2020
Open Access

Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up

Blood Cancer Journal
Jerome PaillassaXavier Troussard

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Castleman Disease

Castleman disease is rare lymphoproliferative disorder unicentric (localized) or multicentric (systemic). Discover the latest research here.

Childhood Vascular Tumor: Genetics

Childhood vascular tumors are formed from cells related to blood vessels or lymph vessels. Here is the latest research on the genetics of childhood vascular tumors.

Chronic Myelogenous Leukemia

Chronic myelogenous leukemia (cml) is a clonal hematopoietic stem cell disorder characterized by the translocation and resultant production of the constitutively activated bcr-abl tyrosine kinase. Here is the latest research on this disease.

Composite Lymphoma

Composite Lymphoma involves different types of lymphoma cells concurrently. Here is the latest research on T-cell leukemia.

© 2020 Meta ULC. All rights reserved